Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells

Jones, Courtney L., Stevens, Brett M., D'Alessandro, Angelo, Reisz, Julie A., Culp-Hill, Rachel, Nemkov, Travis, Pei, Shanshan, Khan, Nabilah +8 more·2018·Cancer Cell

DOI 10.1016/j.ccell.2018.10.005

Cited by (591)

Items 401–500 of 591

Essential Amino Acid Metabolism-Related Molecular Classification in Triple-Negative Breast Cancer
Yajie Zhao, Chunrui Pu, Dechuang Jiao, Jiujun Zhu, Xuhui Guo, Zhenzhen Liu · 2021 · Epigenomics
Mitochondrial determinants of response and resistance to venetoclax plus cytarabine duplet therapy in acute myeloid leukemia
Claudie Bosc, Noémie Gadaud, Aurélie Bousard, Marie Sabatier, Guillaume Cognet, Estelle Saland, Thomas Farge, Emeline Boët, Mathilde Gotanègre, Nesrine Aroua et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Break the lifeline of AML cells
Yoko Tabe, Marina Y Konopleva · 2021 · Blood
Translational control of leukemic metabolism and disease progression
François Mercier, Victor Gife, Raquel S. Aloyz, Laura Hulea · 2025 · Trends in Cell Biology
How to drug a leukemic stem cell: deciphering heterogeneity for better specificity
Alice Worker, Nicholas Jinks, Peter Woodmancy, Claire Seedhouse, Sophie G. Kellaway · 2025 · Blood Neoplasia
Redox–Amino Acid Metabolic Crosstalk in Ovarian Cancer Stem Cells: Integrating Metabolic Reprogramming, Signaling, and the Tumor Microenvironment
Dan Liu, Hua-Wei Yi, Cunjian Yi · 2025 · Antioxidants
Stroma-driven horizontal transfer of TCA-related proteins mediates metabolic plasticity and imatinib resistance in chronic myeloid leukemia
Piotr Chrościcki, Nikodem Kasak, Dorota Dymkowska, Laura Turos-Korgul, Dominik Cysewski, Vira Chumak, Dawid Stępnik, Monika Kusio-Kobiałka, Agata Kominek, Magdalena Lebiedzińska et al. · 2025 · Cell Communication and Signaling
Therapy-Induced Mitochondrial Dysfunction and Metabolic Plasticity in Myeloid Malignancies
Eunseuk Lee, Franklyn Vega Batista, Sharon Susan Paul, Anshu Sutihar, Dana Al-Assi · 2026 · Clinical bioenergetics
Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia
Yanchun Li, Christopher S. Seet, Ryan Michael Mack, Kanak Joshi, Austin P Runde, Patrick Alan Hagen, Kevin Barton, Peter Breslin, Ameet R. Kini, Hong‐Long Ji et al. · 2023 · Stem Cell Reports
ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells
Benigno C. Valdez, Bin Yuan, David L. Murray, Jeremy Ramdial, Uday Popat, Yago L. Nieto, Börje S. Andersson · 2024 · Oncotarget
The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia
Clément Larrue, Sarah Mouche, Jérôme Tamburini · 2024 · Blood Advances
Tyrosine Kinase Inhibitor Therapy Enhances Stem Cells Profile and May Contribute to Survival of Chronic Myeloid Leukemiastem Cells
Simone Rocco, Alessandro Maglione, Valentina Schiavo, Alessandro Ferrando, Carmen Fava, Daniela Cilloni, Barbara Pergolizzi, Cristina Panuzzo · 2025 · Journal of Clinical Medicine
Characteristic, Regulation and Targeting Strategies of Cancer Stem Cells and Their Niche in Digestive System Tumors
Zhenzhen Chen, Huanle Qi, Yapeng Xue, Yaqi Zhang, Zhuo Zhang, Shun Xu, Shixin Liao, Xiaoyu Zeng, Jiayi Wu, Xinrui Lv et al. · 2025 · MedComm – Oncology
White Adipocyte Stem Cell Expansion Through Infant Formula Feeding: New Insights into Epigenetic Programming Explaining the Early Protein Hypothesis of Obesity
Bodo Clemens Melnik, Ralf Weiskirchen, Swen Malte John, Wolfgang Stremmel, Claus Leitzmann, Sabine Weiskirchen, Gerd Schmitz · 2025 · International Journal of Molecular Sciences
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine
Chiara R. Dart, Nabanita Mukherjee, Carol M. Amato, Anabel Goulding, Morgan L. MacBeth, Robert J. Van Gulick, Kasey L. Couts, James R. Lambert, David Albert Norris, William Allen Robinson et al. · 2021 · Pharmaceuticals
Future perspective: metabolism as a therapeutic target in acute myeloid leukemia – from Warburg to precision medicine
Kimberley Joanne Hatfield, Ida Sofie Grønningsæter, Håkon Reikvam · 2021 · Current Medical Research and Opinion
Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia
Sara Ribeiro, Anna M. Eiring, Jamshid Sorouri Khorashad · 2021 · Cancers
Raman identification of single cell component and FMS‐like tyrosine kinase 3‐internal tandem duplications subtype for clinical acute myeloid leukemia
Yimeng Wang, Yihui Wu, Mingbo Chi, Mingxin Li, Sujun Gao, Long Su, Wei Han · 2023 · Journal of Raman Spectroscopy
The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients
Moon Nyeo Park · 2023 · International Journal of Molecular Sciences
Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia
Wanxue Huang, Shasha Zheng, Qi Wang, Na Zhao, Zhiguo Long · 2023 · Scientific Reports
The recombinant l-lysine α-oxidase from the fungus Trichoderma harzianum promotes apoptosis and necrosis of leukemia CD34 + hematopoietic cells
Mariana do Nascimento Costa, Thiago Aparecido da Silva, Dimitrius Santiago P.S.F. Guimarães, Rafael Ricci-Azevedo, Felipe R. Teixeira, Leonardo R. Silveira, Marcelo D. Gomes, Vitor Marcel Faça, Eduardo Brandt Oliveira, Rodrigo T. Calado et al. · 2024 · Microbial Cell Factories
Stress-Induced Proteasome Sub-Cellular Translocation in Cardiomyocytes Causes Altered Intracellular Calcium Handling and Arrhythmias
Shunit Neeman-Egozi, Ido Livneh, Irit Dolgopyat, Udi Nussinovitch, Helena Milman, Nadav Cohen, Binyamin Eisen, Aaron J. Ciechanover, Ofer Binah · 2024 · International Journal of Molecular Sciences
Paper Spray Ionization Mass Spectrometry Coupled with Paper-Based Three-Dimensional Tumor Model for Rapid Metabolic Gradient Profiling
Huimin Liu, Liujuan Zhan, Jia Zhao, Shan Zhang, Hao Yin, Zhuanghao Hou, Guangming Huang · 2024 · Analytical Chemistry
METTL3/YTDHF1 Stabilizes CSRP1 mRNA to Regulate Glycolysis and Promote Acute Myeloid Leukemia Progression
Lili Han, Ruiyan Wang, Mengyu He, Zhenyue Chen, Feng Wang · 2024 · Cell Biochemistry and Biophysics
Cellular and Molecular State of Myeloid Leukemia Stem Cells
Xueqin Xie, Mengdie Feng, Qifan Wang, Jiazhen Wang, Rong L. Yin, Yicun Li, Haojian Zhang · 2019 · Advances in experimental medicine and biology
Post-hoc Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMA
Justin M. Watts, Tara L. Lin, Alice S. Mims, Prapti Arvind Patel, Cynthia Lee, Anoush Shahidzadeh, Paul J. Shami, Elizabeth H. Cull, Christopher Ramin Cogle, Eunice S. Wang et al. · 2022 · Frontiers in Oncology
Metabolic instruction of the graft-versus-leukemia immunity
Ann‐Cathrin Burk, Petya Apostolova · 2024 · Frontiers in Immunology
Mitochondrial metabolism: Critical mechanisms underpinning normal hematopoietic stem cell and acute myeloid leukemia stem cell function
Hui Yu, Lin Yan · 2025 · Gene
OGFOD1 enables AML chemo- and nutrient stress resistance by regulating protein synthesis
Christina Mayerhofer, Dan Li, Trine Ahn Kristiansen, Ernst Mayerhofer, Azeem Sharda, Giulia Schiroli, Karin Gustafsson, Lingli He, Michael Mazzola, Sam Keyes et al. · 2026 · Klinische Pädiatrie
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells
Gentaro Kawano, Riichiro Ikeda, Daisuke Ishihara, Takahiro Shima, Teppei Sakoda, Shunsuke Yamamoto, Yu Kochi, Yuichiro Semba, Sanae Ashitani, Yasuo Mori et al. · 2025 · Blood
Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation
Tianyi Ling, Cristiana O’Brien, Jonathan R. St‐Germain, Vincent Rondeau, Mary Y. Shi, Jacob M. Berman, Adrianna Kinga Cepa, Paula Saez Raez, Mark Wunderlich, Katharine Marie Carter et al. · 2025 · Blood
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets
Shih-Chun A. Chu, Yi Hsiao, Chenwei Wang, Jennifer E Kyle, Raghav Jain, Yamei Deng, Marina Gritsenko, Leanne E. Henry, Jonathan Thomas Lei, Yongchao Dou et al. · 2026 · Nature Cancer
The Immuno-Oncology and Genomic Aspects of DNA-Hypomethylating Therapeutics in Acute Myeloid Leukemia
Akiko Urabe, SungGi Chi, Yosuke Minami · 2023 · International Journal of Molecular Sciences
Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score‐matched analysis
Rong Wang, Yi Zhang, Jie Chang, Huafeng Wang, Yinjun Lou, Min Yang, Gaixiang Xu, Hongyan Tong, Wanzhuo Xie, De Zhou et al. · 2024 · Hematological Oncology
Ferroptosis-Related Gene Signature for Prognosis Prediction in Acute Myeloid Leukemia and Potential Therapeutic Options
Yaonan Hong, Qi Liu, Chuanao Xin, Huijin Hu, Zhenchao Zhuang, Hangping Ge, Yingying Shen, Yuechao Zhao, Yuhong Zhou, Baodong Ye et al. · 2024 · International Journal of General Medicine
Unlocking the Heterogeneity in Acute Leukaemia: Dissection of Clonal Architecture and Metabolic Properties for Clinical Interventions
Martina Maria Capelletti, Orsola Montini, Emilio Ruini, Sarah Tettamanti, Angela Maria Savino, Jolanda Sarno · 2024 · International Journal of Molecular Sciences
PPARγ-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AML
Kotoko Yamatani, Tatsuro Watanabe, Kaori Saito, Abdullah Khasawneh, Abhishek Maiti, Zhihong Zeng, Kala Hayes, Shinya H Kimura, Courtney Denton Dinardo, Xiaoping Su et al. · 2025 · Blood Neoplasia
Rapid clonal selection within early hematopoietic cell compartments presages the outcome of ivosidenib combination therapy
Sven Turkalj, Bilyana Stoilova, Angus Groom, Felix A. Radtke, Rabea Mecklenbrauck, Niels Asger Jakobsen, Curtis Andrew Lachowiez, Marlen Metzner, Batchimeg Usukhbayar, Mirian Angulo Salazar et al. · 2025 · Blood
TP53 Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective
Federico Zingarelli, Letizia Zannoni, Antonio Curti · 2022 · Hemato
Chiral cholesteric molecular tweezer artificial receptors 7a for the rapid detection of tryptophan and the chiral resolution of D-/-tryptophan
Shan Li, Zhe Liu, Ying Ye, Lixia Luo, Lijuan Han · 2023 · Journal of Food Composition and Analysis
An updated outlook on autophagy mechanism and how it supports acute myeloid leukemia maintenance
BGS Macedo, Manuela Albuquerque de Melo, Diego A. Pereira‐Martins, João Agostinho Machado‐Neto, Fabı́ola Traina · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Metabolic landscape and rewiring in normal hematopoiesis, leukemia and aging
Hui Fang, Eunsun Yu, Chang Liu, Christy Eapen, Chunming Cheng, Tianxiang Hu · 2025 · Seminars in Cancer Biology
Myeloma mesenchymal stem cells’ bioenergetics afford a novel selective therapeutic target
Oded Komemi, Elina Orbuch, Osnat Jarchowsky-Dolberg, Yaron Shraga Brin, Shelly Tartakover‐Matalon, Metsada Pasmanik‐Chor, Michael Lishner, Liat Drucker · 2025 · Oncogenesis
Meta-analysis on the effectiveness and safety of venetoclax-based combination therapy with hypomethylation in acute myeloid leukemia
Junqing Wang, Yingying Chen, Dongdong Ji, Ling Ge, Yu Xin Zhang, Lixia Liu, Lei Jiang, Fengbo Jin, Leiming Xia · 2025 · European journal of medical research
An “EZ” Epigenetic Road to Leukemia Stem Cell Metabolic Reprogramming?
Meng Li, Ari M. Melnick · 2019 · Cancer Discovery
Development and Validation of an Individualized Metabolism-Related Prognostic Model for Adult Acute Myeloid Leukemia Patients
Cong Wei, Lijuan Ding, Qian Luo, Xiaoqing Li, Xiangjun Zeng, Delin Kong, Xiaohong Yu, Jingjing Feng, Yishan Ye, Limengmeng Wang et al. · 2022 · Frontiers in Oncology
Amino acid profile changes during enrichment of spheroid cells with cancer stem cell properties in MCF ‐7 and MDA‐MB ‐231 cell lines
Zahra Ghanbari Movahed, Maryam Moghaddam Matin, Kamran Mansouri, Sajjad Sisakhtnezhad · 2023 · Cancer Reports
Targeting LSCs: Peeling Back the Curtain on the Metabolic Complexities of AML
Tian Yi Zhang, Ravindra Majeti · 2020 · Cell stem cell
TIFAB modulates metabolic pathways in KMT2A::MLLT3−induced AML through HNF4A
Yang Wang, Yan Xiu, Qianze Dong, Jinming Zhao, Kelao Neumbo, Masaru Miyagi, Nicholas C. Borcherding, Lin Fu, Havana Ray De Celis, Nicolas Giuseppe Pintozzi et al. · 2024 · Blood Advances
DHX9 as a prognostic biomarker and its biological roles in acute myeloid leukemia
Yacen Xiong, Yan Chen, Huixin Luo, Minhui Shi, Chong Wang, Xueyang Hu, Huaiping Zhu · 2025 · BMC Cancer
Autophagy and Lipid Metabolism as a Therapeutic Target for Overcoming Drug Resistance in Acute Myeloid Leukemia
Seyed Mohammadreza Bolandi, Mahdi Pakjoo, Briandy Fernandez-Marrero, Amir Reza Boskabadi, Erfan Mohammadi Sephavand, Jamshid Sorouri Khorashad, Saeid Ghavami, Anna M. Eiring · 2026 · Life
Leukemic stem cells as drivers of therapeutic resistance in acute myeloid leukemia
Suellen L. R. Silva, Gabriela A. da C. Barbosa, João V.B. Rios, Daniel Pereira Bezerra · 2026 · Biomedicine & Pharmacotherapy
Venetoclax in combination with nucleoside analogs in acute myelogenous leukemia
Brian J. Ball, Paul Koller, Vinod A. Pullarkat · 2022 · Current Opinion in Oncology
Metabolism in Hematopoiesis and Its Malignancy
Xiaoyuan Zeng, Yi-Ping Wang, Cheuk Him Man · 2023 · Advances in experimental medicine and biology
Cancer Drug Resistance and Metabolic Reprogramming
Shariqa Jan, Kaneez Fatima, Abubakar Wani, Fayaz Ahmad Malik, Sameer Ullah Khan · 2024 · Springer eBooks
Feasibility and Safety of Targeting Mitochondria Function and Metabolism in Acute Myeloid Leukemia
Patryk Firmanty, Monika Chomczyk, Shubhankar Dash, Marina Y Konopleva, Natalia Baran · 2024 · Current Pharmacology Reports
Recent trends in research on the role of cholesterol in leukemia: a bibliometric and visualization study
Huijuan Lv, Ke Lu, Ximing Wang, Yanfang Zhang, Mengqi Zhuang, Jing Li, Keli Su, Wen Gao · 2025 · Frontiers in Immunology
An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia
Tamer Adel Othman, Matthew E. Tenold, Benjamin Moskoff, Tali Azenkot, Brian Andrew Jonas · 2021 · Expert Review of Hematology
SOHO State of the Art Updates and Next Questions: The Past, Present and Future of Venetoclax-Based Therapies in AML
Anagha Inguva Sheth, Daniel Aaron Pollyea · 2021 · Clinical Lymphoma Myeloma & Leukemia
Hoxa9 / meis1 -transgenic zebrafish develops acute myeloid leukaemia-like disease with rapid onset and high penetrance
Wei Wang, Hongji Li, Mengling Huang, Xue Wang, Wei Li, Xiaoqing Qian, Lili Jing · 2022 · Open Biology
Salvage treatment in IDH1 mutated acute lymphoblastic leukemia with venetoclax plus methotrexate and pegaspargase: A case report
Dan Li, Shuqi Zhao, Liping Mao, Jie Jin, Jinghan Wang · 2023 · Genes & Diseases
Comprehensive Analysis to Reveal Amino Acid Metabolism-Associated Genes as a Prognostic Index in Gastric Cancer
Gangjun Zhao, Mi Wu, Qiuwen Yan · 2023 · Mediators of Inflammation
Construction and validation of an NAD + metabolism-related lncRNA signature for predicting the prognosis and immune landscape of acute myeloid leukemia
Yu Zhu, Jinli Jian, Yujie Niu, Xiaoxiao Yang, Yuancheng Guo, Long Zhao, Bei Liu · 2023 · Hematology
Metabolic dysregulation in myelodysplastic neoplasm: impact on pathogenesis and potential therapeutic targets
Hao Zhou, Wenqiong Xiang, Guangyu Zhou, Fernando Rodrigues‐Lima, Fabien Guidez, Li Wang · 2024 · Medical Oncology
Hypomethylating agents with venetoclax: have we discovered the holy grail?
Jonathan Aaron Gutman, Daniel Aaron Pollyea · 2019 · Current Opinion in Hematology
Targeting Amino Acids to Treat AML
Xuan Zhou, Bei Cao, Juan Li · 2020 · Journal of Clinical Haematology
Tafazzin modulates cellular phospholipid composition to regulate AML stemness
Ayesh K. Seneviratne, Mingjing Xu, Aaron David Schimmer · 2019 · Molecular & Cellular Oncology
Metabolism in hematology: Technological advances open new perspectives on disease biology and treatment
Eileen Haring, Joerg Martin Buescher, Petya Apostolova · 2025 · HemaSphere
Amino acid-based risk stratification model improves prognostic precision in diffuse large B-cell lymphoma
Chaowei Zhang, Mingyue Cai, Weiyi Yao, Qing Hong, Yuxuan Han, Na Chen · 2025 · Cancer Cell International
Loss of FBXO11 establishes a stem cell program in acute myeloid leukemia by dysregulating LONP1
Hayle Kincross, Ya-Chi Angela Mo, Xuan Wang, Linda Chang, Gerben Duns, Franziska Mey, Jihong Jiang, Zurui Zhu, Naomi Isak, Harwood Kwan et al. · 2025 · Journal of Clinical Investigation
Mechanistic overview and suggested strategies to overcome BCL-2 inhibitor resistance in TP53-mutated acute myeloid leukemia
Umar Iqbal, Rory Michael Shallis · 2026 · Frontiers in Cell and Developmental Biology
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic Malignancies
Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, Mamdouh Skafi, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Graziella D’Arrigo, Virginia Olivito, Caterina Labanca et al. · 2026 · European Journal Of Haematology
A multifaceted and feasible prognostic model of amino acid metabolism-related genes in the immune response and tumor microenvironment of head and neck squamous cell carcinomas
Wei Li, Zhefei Zou, Ning An, Ming‐Wei Wang, Xiguo Liu, Zhidan Mei · 2022 · Frontiers in Oncology · Retracted
Cancer Stem Cells and Treatment of Cancer: An Update and Future Perspectives
Mudassir Khan, Mashal Naeem, Sana Aftab Chaudary, Affan Ahmed, Aftab Ahmed · 2023 · Current Stem Cell Research & Therapy
A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia
BGS Macedo, Manuela Albuquerque de Melo, Diego A. Pereira‐Martins, João Agostinho Machado‐Neto, Fabı́ola Traina · 2025 · Hematology Transfusion and Cell Therapy
Phosphatidic acid phosphatase LPIN1 in phospholipid metabolism and stemness in hematopoiesis and AML
Karin Huber, Swati Garg, Lena P. Schlautmann, Rui Wang, Lixiazi He, Richard Huth, Alireza Pouya, Christian Rohde, Maike Janssen, Christian Lüchtenborg et al. · 2025 · HemaSphere
[A Review of the Redox Regulation of Tumor Metabolism].
Kui Wang, Hui Ming, Jing Zuo, Hailong Tian, Canhua Huang · 2021 · PubMed Central
AML: making residual disease more measurable
Maria Teresa Voso, Francesco Buccisano · 2022 · Blood
Reduced mitochondrial transcription sensitizes acute myeloid leukemia cells to BCL-2 inhibition
Laleh S. Arabanian, Jenni Adamsson, Anke Unger, Raffaella Di Lucrezia, Tim Bergbrede, Arghavan Ashouri, Erik Larsson, Peter Nußbaumer, Bert Klebl, Lars Palmqvist et al. · 2024 · eLife
Purine metabolites regulate leukemic cell sensitivity toward cytarabine
Xiaowen Zhang, Ang Jia, Jianwei You, Zixuan Zhuang, Yinfei Wang, Ting Liu, Xingrong Du, Linzhang Huang, Peng Li, Tong‐Jin Zhao et al. · 2025 · Haematologica
Mitochondrial micro RNAs: Crucial players in carcinogenesis
Ashutosh Kumar Maurya, Anjali Sangeeth, Rabina Punathil, R. Grace Raji, V.B. Sameer Kumar · 2025 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Impact of physiological media on acute myeloid leukemia bioenergetics and cell proliferation
Brett R. Chrest, McLane M. Montgomery, Raphael Taiwo Aruleba, Polina M. Krassovskaia, Emely A. Pacheco, James T. Hagen, Kayla J. Vandiver, Kang Tung, Molly Alexander, Nicholas C. Williamson et al. · 2025 · Cancer & Metabolism
Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial
Daniel Aaron Pollyea, Brett M. Stevens, Diana Abbott, Maria Amaya, Jonathan Aaron Gutman, Andrew Kent, Christine M. McMahon, Marc Schwartz, Clayton A. Smith, Jessie Dell-Martin et al. · 2025 · EClinicalMedicine
Diagnostic updates and research advances in AML-MR: Integrating molecular genetics and immune mechanisms
Nan Wang, Zuxi Feng, Hanxue Zheng, Xixi Chen, Xiaofei Cong, Liansheng Zhang, Lijuan Li · 2026 · Leukemia Research
The crosstalk between epigenetics and metabolism in the malignant cell
Adrian Bogdan Țigu, Andrei Ivancuta, Catalin Sorin Constantinescu, Vlad Moisoiu, Olga Grăjdieru, Ciprian Cucoreanu, Mădălina Nistor, Dávid Kegyes, Anamaria Bancos, Victor Tomacinschii et al. · 2026 · Discover Oncology
Exploring the Bone Marrow Microenvironment as a Therapeutic Barrier and Targetable Source of Crosstalk in Acute Myeloid Leukemia
Kolosova A, Mould IA, Chris J. Pepper, Simon Mitchell, Andrea G. S. Pepper, Eleni E Ladikou, Fabio A. Simoes · 2026 · Blood and Lymphatic Cancer Targets and Therapy
Realgar transforming solution suppresses KG-1a-derived CD34+CD38− acute myeloid leukemia stem cell-like phenotypes in association with ER-mitochondrial stress and mitophagy-related alterations
Teng Wang, Weilin Liu, Chunyi Lyu, Yunxiao Luo, Xinyu Tang, Chen Han, Ruirong Xu · 2026 · Journal of Ethnopharmacology
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics
Xin He, Lei Zhang, Y Li, Songbai Liu, Zheng Li, Haojie Dong, Genevieve E. Baker, Le Xuan Truong Nguyen, Wei Chen, Jinhui Wang et al. · 2026 · Nature Cancer
Targeting ACSF2 overcomes Ara-C resistance in acute myeloid leukemia via the cholesterol metabolism-ERK signaling axis
Chenxi Liao, Jin Feng Wen, Xiao Ma, Nan Wang, Ying Chen, Lei Li, Lingbo Liu, Danyue Peng · 2026 · Leukemia
Fractionated irradiation induces radioresistant oral carcinoma cells with enhanced malignant phenotypes
Yangfan Liu, Tongxu Sun, Jin Yang, Jingjing Luo, Hongmei Zhou · 2024 · Archives of Oral Biology
Influences on the Hematopoietic Stem Cell Niche
Brian M Barth · 2024
Preclinical targeting of leukemia-initiating cells in the development future biologics for acute myeloid leukemia
Jiaxin Dong, Marina Y Konopleva · 2025 · Expert Opinion on Therapeutic Targets
Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia
Lacey C. Brennan, Aru Narendran · 2019 · Stem Cells and Development
No keto for AML stem cells!
Britta Will · 2020 · Blood
Mitochondria in Their Prime Drive Venetoclax Response in Acute Myeloid Leukemia
Mette C. Kriegbaum, Krister Wennerberg · 2020 · Cancer Cell
Impact of Dietary Interventions on Cancer Stem Cells
Rajesh Nivarti Gacche · 2021 · Springer eBooks
Changes in free amino acid contentrations in blood serum of children with acute lymphoblastic leukemia and lymphomas after chemotherapy
Elena V. Zhukovskaya, Татьяна Викторовна Коробейникова, Alexander F. Karelin, А.П. Гончаров, Д.С. Рахаев, П.Ф. Литвицкий · 2022 · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia»
Genetic Landscape of Electron Transport Chain Complex I Dependency in Acute Myeloid Leukemia
Irène Baccelli, Yves Gareau, Bernhard Lehnertz, Stéphane Gingras, Jean-François Spinella, Alexandre Beautrait, Sophie Corneau, Nadine Mayotte, Isabel Boivin, Simon Girard et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
A primary patient-derived model for investigating functional heterogeneity within the human Leukemic Stem Cell Compartment
Héléna Boutzen, Michelle Chan‐Seng‐Yue, Alex Murison, Nathan Mbong, Elvin Wagenblast, Christopher Arlidge, Seyed Ali Madani Tonekaboni, Elias Orouji, Andrea Arruda, Amanda Mitchell et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
A comprehensive single-cell expression atlas of human AML leukemia-initiating cells unravels the contribution of HIF pathway and its therapeutic potential
Talía Velasco-Hernández, Juan L. Trincado, Meritxell Vinyoles, Adrià Closa, Francisco Gutiérrez‐Agüera, Òscar Molina, Virginia Rodríguez-Cortez, Paolo Petazzi, Sergi Beneyto‐Calabuig, Lars Velten et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)